MAGI2 Mutations Cause Congenital Nephrotic Syndrome
Agnieszka Bierzynska1, Katrina Soderquest2, Philip Dean3
1Bristol Renal and Children's Renal Unit, School of Clinical Sciences, University of Bristol, Bristol, United Kingdom.
Journal of the American Society of Nephrology : JASN
|December 10, 2016
Summary
New genetic mutations in MAGI2 cause congenital nephrotic syndrome. This finding advances understanding of steroid-resistant nephrotic syndrome (SRNS) and its genetic underpinnings in children.
Area of Science:
- Genetics and Molecular Biology
- Nephrology and Renal Medicine
- Pediatric Diseases
Background:
- Steroid-resistant nephrotic syndrome (SRNS) is a kidney disorder impairing glomerular filtration, with genetic causes identified in only a fraction of patients.
- Mutations in podocyte genes disrupt the glomerular filtration barrier, leading to SRNS, but the genetic landscape remains incompletely understood.
- Congenital nephrotic syndrome (CNS) is a severe form of SRNS with early onset, often linked to recessive genetic mutations.
Purpose of the Study:
- To identify novel genetic causes of congenital and childhood-onset SRNS.
- To investigate the role of the MAGI2 gene in the pathogenesis of SRNS.
- To establish a link between MAGI2 mutations and podocyte dysfunction in SRNS.
Main Methods:
- Whole-exome sequencing was performed on a cohort of patients with congenital/childhood-onset SRNS.
- Identification and characterization of mutations in the MAGI2 gene.
- Immunohistochemistry was used to assess MAGI2 protein expression in patient kidney biopsies.
Main Results:
- Novel frameshift and duplication mutations in the MAGI2 gene were identified in three patients from two families with SRNS.
- These mutations were predicted to cause premature stop codons or translational read-through, affecting MAGI2 protein function.
- Reduced or absent MAGI2 protein expression was observed in podocytes of affected patients, correlating with disease presence.
Conclusions:
- Mutations in the MAGI2 gene are a newly identified cause of congenital SRNS.
- MAGI2 plays a critical role in podocyte function and the integrity of the glomerular filtration barrier.
- These findings expand the spectrum of genetic SRNS and highlight MAGI2 as a potential therapeutic target.
Related Concept Videos
Inborn Errors of Metabolism
972
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
972
Nephrotic Syndrome I : Introduction
796
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
796
Nephrotic Syndrome II : Assessment and Medical Management
292
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
292
Glucose Transporters
27.9K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.9K
Mutations
95.5K
Overview
95.5K
Overview of Protein Metabolism
4.4K
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
4.4K


